Hepatitis Drugs Markets in China

Published: Jun, 2019 | Pages: 196 | Publisher: Asia Market Information & Development Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

China's demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

 TABLE OF CONTENTS

 I. INTRODUCTION  

  Report Scope and Methodology  
  Executive Summary  

 II. BUSINESS ENVIRONMENT  
  
  Economic Outlook  
   Key Economic Indicators   
   Industrial Output  
   Population and Labor   
   Foreign Investment   
   Foreign Trade  
  Financial and Tax Regulations  
   Banking System and Regulations  
   Foreign Exchange   
   Taxes, Tariff and Custom Duties  

 III.  HEPATITIS DRUGS INDUSTRY ASSESSMENTS  

 Hepatitis Drugs Industry Structure
        Market Size
        Market Growth Drivers
         Hepatitis Drugs Industry Sales Volumes    
  Major Producer Facility Locations and Sales Volumes    
  Market Share of Key Producers  
  Labor Cost
        Potential Entrants
        Major Distributors  
  Major Foreign Investment  
  Technology Development
  

 IV.  HEPATITIS DRUGS PRODUCTION AND DEMAND  

  Overview
        Sales Volumes of Hepatitis Drugs by Region     
  Hepatitis Drugs Sales Volumes  
  Liver Protection Drugs
           Nucleoside Drugs
  Interferon (IFN)
           Other Hepatitis Drugs 
  Hepatitis Drugs Imports and Exports
          Hepatitis Drugs Imports
          Hepatitis Drugs Exports
Pricing Trend  
 

 V. HEPATITIS DRUGS MARKET OUTLOOK   

  Hepatitis Drugs Market Outlook Overview  
  Government Regulation
  Health Care Insurance Industry Overview
  Consumer Spending Trends
  Demographic Trends
  Health Care Industry Trends
  Hospitals and Hospital Beds
  Physicians and Physician Visits  


 VI. MARKETING STRATEGIES  

  China Market Entry Overview  
   China's Distribution System   
   Hepatitis Drugs Distribution Channels  
   Transportation and Freight Infrastructure
   Communications  
  China’s Market Entry
         Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises


   
 VII. HEPATITIS DRUGS PRODUCER DIRECTORY  

  Hepatitis Drugs Producer Profiles  
    
  


LIST OF TABLES



 I. INTRODUCTION  

  Economic Outlook Summary  
   

 II. BUSINESS ENVIRONMENT  
 
  Key Economic Indicators   
  Industrial Output
  Population and Labor Force Trends  
  Foreign Investment and Loans  
  Foreign Trade    

 III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS  

  Hepatitis Drugs Industry Sales Volumes  
  Major Producer Facility Locations  
  Major Hepatitis Drugs Producer Sales Volumes  
  Market Share of Key Producers    
  Major Foreign Investments in China  

 IV. HEPATITIS DRUGS PRODUCTION AND DEMAND  

Hepatitis Drugs Sales Volumes
Sales Volumes of Hepatitis Drugs by Region 
        Major Liver Protection Drugs Producer Sales Volumes
        Liver Protection Drugs Sales Volumes
        Major Nucleoside Drugs Producer Sales Volumes
        Nucleoside Drugs Sales Volumes
        Major IFN Drugs Producer Sales Volumes
        Interferon (IFN) Sales Volumes
        Other Hepatitis Drugs Sales Volumes
        China Hepatitis Drugs Imports and Exports


  

 V. HEPATITIS DRUGS MARKET OUTLOOK   

  Total hepatitis Drugs Sales Volumes by Market
  Hepatitis Drugs Sales Volumes and Market Share
  Consumer Spending Trends
  Demographic Trends
        Health Care Industry Trends
        Hospitals and Hospital Beds
        Physicians and Physician Visits


LIST OF CHARTS



I.   INTRODUCTION  
  
  China’s Hepatitis Drugs Sales Volumes  

 II. BUSINESS ENVIRONMENT  
 
  China’s GDP and Growth Rate   
  Industrial Output by Ownership
        China’s Imports and Exports  

 III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS  

  Hepatitis Drugs Sales Volumes in China  
 
 IV. HEPATITIS DRUGS PRODUCTION AND DEMAND  

         Total Hepatitis Drugs Sales Volumes     
         Total Hepatitis Drugs Imports and Exports
 
 V. HEPATITIS DRUGS MARKET OUTLOOK   

        Hepatitis Drugs Sales Volumes by Market 
 
VI. MARKETING STRATEGIES
   
    China’s Distribution Channel